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680Objective: Comorbidities predisposing cardiac surgical patients toward deep sternal wound infection, such as
diabetes and obesity, are rising in the United States. Longitudinal analysis of risk factors, morbidity, and mortality
was performed to assessed effects of these health trends on deep sternal wound infection rates.
Methods: In this retrospective analysis of all median sternotomies performed at a single institution from 1991
through 2006, demographic and surgical characteristics were identified from a prospective database. The cohort
was separated into periods from 1992 through 2001 and 2002 through 2006 to identify longitudinal trends in risk
factors for deep sternal wound infection. Univariate and matched multivariable analyses were performed.
Results: Overall, study population had increased comorbidities associated with deep sternal wound infection
such as obesity, diabetes, and advanced age. Deep sternal wound infections were treated in 285 of 21,000 ster-
notomies performed during study period (1.35%). Deep sternal wound infection rates decreased from 1.57% to
0.88% in last 5 years. Rate of deep sternal wound infection was reduced among patients with diabetes from 3.2%
to 1.0%. Multivariable analysis showed diabetes and smoking to be eliminated as risk factors in last 5 years. Pro-
longed bypass time was the only variable independently associated with deep sternal wound infection for the
entire period. Thirty-day and 1-year mortalities for deep sternal wound infection did not change significantly.
Conclusions: Analysis of a large series of cardiac surgical patients demonstrates significant reduction in deep
sternal wound infection incidence in 15 years. Introduction of perioperative intravenous insulin may explain
some observed risk reduction. Efforts should focus on prevention, because mortality remains elevated. (J Thorac
Cardiovasc Surg 2010;139:680-5)Even in the modern era, deep sternal wound infections
(DSWIs) remain a major source of morbidity and mortality
for patients after cardiac surgical procedures. Medical liter-
ature documents current rates of DSWI to be between 0.5%
and 3%, with a high number of associated complications,
prolonged stays, and increased hospital costs.1,2 Treatment
and outcomes of sternal wounds have improved significantly
with early detection, aggressive de´bridement, advanced
wound treatments, and the use of regional muscle flaps.3,4
Historical mortality rates for mediastinitis, previously re-
ported as up to 50%, have been reduced but remain elevated
at 3% to 35%.1,2
In an effort to decrease rates of DSWI, large retrospective
and prospective outcome studies have identified epidemio-
logic factors associated with this complication. A partial
list of commonly cited risks includes advanced age, obesity,
diabetes, smoking, prolonged operative time, use of internal
thoracic artery conduits, hemodialysis, and reoperative sur-
gery.1,5 These factors are generally not modifiable at the
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The Journal of Thoracic and Cardiovascular Surgwhich advances in cardiac surgery and anesthesia contribute
to primary prevention. Technical improvements include
smaller incisions, off-pump procedures, topical wound anti-
microbial preparations, endoscopic lower extremity vein
harvesting techniques, and more recently primary sternal
plating for high-risk patients.6,7 Anesthesia care has also im-
proved, with reliable delivery of prophylactic antibiotics,
better resuscitation, and tighter glycemic control in both
the operating room and intensive care units.8-10 Although
some of these interventions have not been tested prospec-
tively, they collectively represent a multifaceted approach
toward risk reduction and DSWI prevention.
During the same period that treatment and outcomes for
DSWI have improved, the demographic background of pa-
tients and indications for cardiac surgery have changed. Re-
cent US health trends demonstrate increasing numbers of
patients with diabetes, rising rates of obesity, and advancing
age of the population. Indications for cardiac surgical proce-
dures have shifted with development of minimally invasive
technology. As the numbers of such percutaneous interven-
tions as balloon angioplasty and stenting increase, patients
who require open-chest heart surgery have more advanced
coronary disease with higher numbers of comorbidities.11,12
Against this background, the cardiac surgical population
appears to have a shifting profile of factors placing them at
increased risk for DSWI.
Because of the changing array of risk factors and preven-
tive measures for sternal infections in cardiac surgicalery c March 2010
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Mpatients, we are interested in understanding how these fac-
tors have interacted to affect development of DSWIs at our
institution with time. Our clinical observation has been
that rates of DSWI decreased during the last 5 years of the
study period, despite what appears to be a sicker patient pop-
ulation. By separating our cohort of patients into distinct pe-
riods, the goals of our study were as follows: (1) to measure
changes in the rate of DSWI and (2) to determine which risk
factors currently play a major role in this important postop-
erative complication.
MATERIALS AND METHODS
This single-institution, retrospective, case-control cohort study was
based on data from a prospectively collected cardiac surgical database. Ster-
nal infections were identified from all cardiac surgical procedures performed
between January 1992 through December 2006 at Brigham and Women’s
Hospital, Boston. DSWI was defined, similar to the definition of Jones
and colleagues,4 as any chest wound infection involving the sternum or me-
diastinal tissues within 12 months after surgery. This definition excluded pa-
tients with superficial infections, such as skin dehiscence or exposure of the
deep fascia, but included those with exposed bone or mediastinal tissues.
Approximately 2 thirds of patients in this study had signs and symptoms
of DSWI in the subacute period between 2 weeks and 1 month after the
date of cardiac surgery.13 This research study was approved by our institu-
tional review board.
Characteristics of the patients and their hospital courses were surveyed
from the database and hospital computer information system. Data were
divided into demographic characteristics, comorbidities, medications, fea-
tures of the cardiac surgical procedure, and microbiologic cultures. Demo-
graphic features included age, sex, height, weight, and body mass index.
Comorbidities evaluated were history of hypertension, hypercholesterol-
emia, pulmonary hypertension, cerebrovascular disease, pulmonary embo-
lism, cardiomyopathy, asthma, anemia, heart failure history and functional
class, chronic obstructive pulmonary disease, renal insufficiency (creatinine
>2.0 mg/dL), history of hemodialysis, presence of diabetes (type 1 and 2 di-
abetes were combined), bleeding history, peripheral vascular disease, recent
myocardial infarction, smoking history, and alcohol use. Preoperative (used
within 48 hours of surgery) medications studied were angiotensin-convert-
ing enzyme inhibitors, diuretics, steroids, immunosuppressants, digitalis,
nitrates, calcium channel blockers, b-blockers, aspirin, warfarin, and post-
operative inotropes. Details of the perioperative insulin regimen used in
our institution have been published previously.14 Patients received either
vancomycin or cefazolin prophylaxis before surgical incision, and prophy-
laxis was discontinued after the second postoperative dose. Skin shaving
was performed with surgical clippers, not razor blades. Bone wax was
used at the discretion of the surgeon. The sternal closure technique used
was simple cerclage with stainless steel wires. Primary or prophylactic ster-
nal plating was not performed during the study period. Other surgical char-
acteristics evaluated were type of operation (coronary artery bypass grafting
[CABG], valve replacement or repair, or other), cardiopulmonary bypass
(CPB) time as a continuous variable, circulatory arrest, lower extremity sa-
phenous vein harvesting, use of 1 or 2 internal thoracic arteries, number of
vein grafts, previous sternotomy, emergency surgery, intra-aortic balloonThe Journal of Thoracic and Capump, ventricular assist device, and need for reoperation. Because of high
rates of infection, patients with open chests at the end of the index cardiac
procedure were excluded from the data analysis.
Perioperative deaths were defined as those that occurred within 30 days
of the index cardiac surgical procedure. Long-term mortality data were de-
termined from hospital encounters and publicly available social security
death indices. Patients who died within 24 hours of the index cardiac
surgical procedure were excluded from the data analysis.
Statistical analysis was performed with SAS (SAS Institute, Inc, Cary,
NC) and SPSS 13.0 (SPSS, Inc, Chicago, Ill) publicly available software.
Variables were examined with the c2 test, Fisher’s Exact Test, and Student
t test as appropriate. To identify independent risk factors for DSWI, a 1:2
case to control matched multivariable stepwise logistic regression model
was performed. Variables with a P value less than .05 by univariate analysis
(Table 2) were included in the final multivariable model (Table 3). Matching
was based on patient age, sex, procedure type, and year of surgery.RESULTS
Important demographic variables and comorbid condi-
tions that have been shown in other studies to contribute
to an increased risk of DSWI were examined longitudinally
in the entire cohort (Table 1). The most recent period from
2002 through 2006 demonstrates that the mean age and
body mass index of patients undergoing cardiac surgery in-
creased significantly (P< .001). A subgroup analysis (data
not shown) demonstrated that the proportion of patients
older than 80 years increased from 10% to 13.4% in the
last 5 years (P< .001). Similarly, the proportion of patients
undergo cardiac surgery who had diabetes increased signif-
icantly, from 24.7% to 26.4% (P< .011). Analysis of the
surgical case mix shows that the frequency of isolated
CABG procedures decreased significantly, whereas rates
of valvular and of combined CABG and valvular operations
increased in the more recent period.
During the 15-year study period, 285 sternal infections
were identified from more than 21,000 cardiac surgical pro-
cedures performed (Figure 1), with a cumulative rate of
1.35% (285/21,191). To identify risk factors that contrib-
uted to the recent decline in DSWIs seen in Figure 1, the co-
hort was dichotomized into groups, with the latter starting in
January 2002. The number of DSWIs before 2002 was 222
(1.57%). Thereafter DSWIs decreased significantly to 63
(0.88%, P< .0001).
A partial list of demographic variables and markers of
morbidity for patients with DSWIs for each period is shown
in Table 2. The proportions of patients who had sternal infec-
tions with advanced age, female sex, renal or heart failure,
and elevated body mass index did not change significantly.
Patients with DSWIs in the last 5 years were significantly
less likely to smoke or to undergo isolated CABG and
were more likely to have a longer CPB time. Between
1992 and 2001, 50% of patients with sternal infections
had diabetes, whereas more recently this rate has decreased
to just a third.
When DSWIs were plotted across time in the subpopula-
tions with and without diabetes, rates of sternal infectionrdiovascular Surgery c Volume 139, Number 3 681
TABLE 1. Rates of comorbid conditions and demographic variables
for all patients
1992–2001
(n ¼ 14,125)
2002–2006
(n ¼ 7066)
P
value
Age (y, mean) 64.8 65.4 .001
Body mass index (kg/m2, mean) 27.2 27.9 .001
Female (%) 33.8% 35.3% .005
Hypertension (%) 54.2% 67.1% .001
Hyperlipidemia (%) 47.3% 66.7% .001
Diabetes (%) 24.7% 26.4% .011
Renal failure (%) 9.1% 9.5% .357
New York Heart Association
class III or IV (%)
36.6% 39.7% .001
Previous cardiac surgery (%) 10.3% 10.0% .589
Bypass time (min, median) 100 118.0 .001
Operation type (%)
CABG* 56.1% 41.8% .001
Left ITA 77.2% 89.5%
Right ITA 0.7% 0.3%
Bilateral ITA 4.1% 3.3%
No ITA use 17.4% 6.6%
Valve 19.6% 32.4% .001
CABG and valve 16.7% 18.2% .005
Other 7.6% 7.5% .734
CABG,Coronary artery bypass grafting, ITA, internal thoracic artery. *The small num-
bers of right and bilateral internal thoracic arterial grafts precludes meaningful statis-
tical analyses by conduit type.
TABLE 2. Rates of comorbid conditions and demographic variables
for patients with sternal wound infection
1992–2001
(n ¼ 222)
2002–2006
(n ¼ 63)
P
value
Age (y, mean) 65.5 66.5 .553
Body mass index (kg/m2, mean) 29.7 29.1 .532
Female (%) 27% 33.3% .327
Hypertension (%) 63.1% 69.8% >.999
Hyperlipidemia (%) 51% 66.7% .031
Diabetes (%) 50% 33.3% .022
Renal failure (%) 14% 9.5% .314
New York Heart Association
class III or IV (%)
36% 39.7% .521
Smoking history (%) 66% 49.0% .028
Aspirin use (%) 61% 59.0% .821
Bypass time (min, median) 103 150 .001
Operation type (%)
CABG* 69.4% 41.3% .001
Left ITA 79.9% 69.2%
Right ITA 0.6% 3.8%
Bilateral ITA 7.1% 3.8%
No ITA use 12.3% 23.1%
Valve 7.2% 27.0% .001
CABG and valve 19.4% 23.8% .479
Other 4.1% 7.9% .208
CABG,Coronary artery bypass grafting, ITA, internal thoracic artery. *The small num-
bers of right and bilateral internal thoracic arterial grafts precludes meaningful statis-
tical analyses by conduit type.
TABLE 3. Multivariable analysis for risk factors associated with
sternal wound infection
Odds ratio
95% Confidence
interval
P
value
1992–2001
Female with body mass
index>30 kg/m2
5.175 1.964–13.635 .001
Diabetes 1.959 1.150–3.338 .013
Smoking 1.961 1.095–3.512 .023
Preoperative aspirin use 2.167 1.260–3.728 .005
Prolonged bypass time 2.300 1.144–4.626 .019
2002–2006
Prolonged bypass time 1.011 1.000–1.022 .054
Univariate variables from Table 2 with P< .05 were included in the multivariate
model.
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Mdecreased in both subgroups, with a more rapid decline the
subgroup with diabetes (Figure 2). Rates of sternal infection
for patients with and without diabetes were evaluated sepa-
rately for each period. Before 2002, patients with diabetes
acquired DSWIs in 3.2% of sternotomies performed, but
this rate decreased significantly to just 1.1% percent more
recently (P< .0001). A similar trend is seen for patients
without diabetes, with infection rates decreased from
1.0% to 0.8% (P ¼ .162).
Identifications of risk factors for sternal infection in each
time period were performed with matched multivariable
logistic regression analyses (Table 3). Risk factors in the co-
hort from 1992 through 2001 were similar to those reported
in the literature. History of diabetes, smoking, female sex
with an elevated body mass index, and long CPB time
were independent predictors for development of DSWI.
Since 2001, only a prolonged CPB time showed a trend as
an independent risk factor for this complication (P< .054).
Seventy percent of patients from the entire cohort had
monomicrobial infections, 29% had polymicrobial infec-
tions, and fewer than 1% had sterile cultures. Overall,
Staphylococcus epidermidis was the most prevalent organ-
ism, cultured in 49% of sternal wounds. Other bacteria
frequently cultured included methicillin-sensitive S aureus
(21%), methicillin-resistant S aureus (18%), Enterococcus
species (1%), and Propionibacterium acnes (1%). There
was no significant change in the distribution of microorgan-682 The Journal of Thoracic and Cardiovascular Surgisms during the study period except for the number of
methicillin-resistant S aureus infections, which increased
significantly from 14.4% to 25.4% (P< .048).
The 30-day and 1-year mortalities associated with DSWI
did not change significantly during the 15-year study period.
Between 1992 and 2001, the 30-day mortality was 1.35%.
In the more recent period from 2002 through 2006, the
rate increased to 3.17%; however, this difference was not
statistically significant. A similar trend was seen in 1-year
mortality, with a nonsignificant increase from 17% in theery c March 2010
FIGURE 1. Numbers of deep sternal wound infections (DSWIs) per year. Bar graph representation of number of deep sternal wound infections per annum for
15-year study period. For statistical analysis, cohort was divided into 2 time periods, latter starting in January 2002.
Matros et al Perioperative Managementperiod from 1992 through 2001 to 22% between 2002 and
2006.P
MDISCUSSION
Numerous studies have evaluated risk factors for DSWI.
This study is unique because it separated a large cohort of
cardiac surgical patients into 2 distinct periods, from 1992
through 2001 and 2002 through 2006. The analysis was per-
formed to highlight longitudinal trends in DSWI risk factors.
Longitudinal data provide useful information for cliniciansFIGURE 2. Longitudinal trends of deep sternal wound infection (DSWI) in
patients with and without diabetes. Graphic representation of all sternal
wounds in 15 years separated by history of diabetes.Dashed lines represent
patients with diabetes, whereas solid lines represent patients without diabe-
tes. Straight lines are slopes associated with corresponding curves.
The Journal of Thoracic and Cato assess whether previous preventative measures have
helped and to identify future areas of intervention for this im-
portant complication. The year 2002 was chosen as the tran-
sition because the decrease in infections observed around
this time would maximize opportunity for the analysis to
identify contributory risk factors (Figure 1).
During the last 5 years of the study period, there was a sig-
nificant decrease in the rate of DSWI at our institution, from
1.57% to 0.88%. This change seems counterintuitive, be-
cause conditions such as obesity and advanced age, which
predispose toward DSWI, have significantly increased
both nationally and within our cardiac surgical patient pop-
ulation (Table 1).11,12 Because these comorbidities are not
amenable to intervention on hospital admission, the ob-
served reduction in DSWI may be explained by changes in
modifiable risk factors.15
The most striking change observed is the decreased asso-
ciation between diabetes and DSWI. Although the preva-
lence of diabetes has increased at our institution (Table 1),
rates of diabetes in patients with DSWI decreased from
50% in the former period to 33% more recently (Table 2).
Subgroup analysis solely of patients with diabetes showed
that DSWI rates were reduced from 3.2% to 1.0% of ster-
notomies performed in this high-risk group. Multivariate
analysis corroborated these findings by demonstrating that
diabetes was no longer an independent risk factor for
DSWI from 2002 through 2006 (Table 3).
Landmark articles have closely linked and suggested
a causal relationship between hyperglycemia and increased
DSWI. An initial report by Zerr and coworkers16 showed
that patients with diabetes who acquired DSWIs had higher
mean blood glucose levels in the first 48 hours postopera-
tively than did uninfected patients with diabetes. Furnaryrdiovascular Surgery c Volume 139, Number 3 683
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Mand colleagues9 showed in a prospective study that intensive
glycemic control with continuous postoperative intravenous
insulin leads to better glucose control and decreased rates of
DSWI relative to subcutaneous insulin regimens. The argu-
ment in favor of intensive insulin therapy is further strength-
ened by reports showing that continuous intravenous insulin
after CABG or in critically ill surgical patients can lead to
a mortality reduction.10,17 Finally, these benefits are seen
not only for patients with overt diabetes but for those with
insulin resistance as well.10 Accordingly, our institution ini-
tiated a protocol of postoperative intravenous administration
of insulin in 2000 (regular use was not achieved until 2002),
followed in 2003 by a protocol intraoperative intravenous
administration of insulin, with improvements in postopera-
tive mean glucose values.14 A portion of the DSWI risk re-
duction observed in this series may be attributable to
perioperative intravenous insulin administration.
Reflective of general US trends, which show a decreased
prevalence of active smokers from 24.7% in 1997 to 19.7%
in 2007, decreased percentages of patients with DSWI were
active smokers at the time of cardiac surgery (Table 2).18 In
the multivariable analysis, smoking was formerly an inde-
pendent risk factor for DSWI between 1992 and 2001, but
this relationship was not true in the more recent period (Ta-
ble 3). These findings suggest that the relative effect of
smoking has diminished because of its decreased prevalence
at the time of surgery. The elevated risk of DSWI associated
with active smoking cannot be normalized after admission;
however, if the number of active smokers in the US con-
tinues to decrease, rates of DSWI and cardiovascular disease
may also decline.
Studies demonstrate associations between smoking, sur-
gical site infections, and increased postoperative morbidity
and mortality.19 The mechanism by which tobacco contrib-
utes to increased rates of DSWI is unknown. Evidence in the
literature demonstrates that smoking causes poor wound
healing directly by reduction in both local blood flow and tis-
sue oxygen tension.20 It is unclear whether the detrimental
tissue effects of smoking can be attributed to nicotine, be-
cause in multiple studies nicotine replacement medications
have failed to affect wound healing adversely.21 An alterna-
tive hypothesis to consider is that smoking-related coughing
causes shear stress at the sternal wires and the hemisternal
junction. Stress along sternal wires causes cutting of wires
through bone, wire breakage, and bony fracture, with a final
common pathway of nonunion secondary to motion. Data
suggest that even relatively small physiologic loads, such
as from a simulated Valsalva maneuver, can cause sternal
dehiscence as a result of wires cutting through the sternum.22
Interestingly, lifting 40 pounds places less force on a median
sternotomy incision than does a cough.23
Prolonged CPB time, a reliable proxy for longer operative
time, was the only variable that was an independent risk
factor for DSWI throughout the entire 15-year study period684 The Journal of Thoracic and Cardiovascular Surg(Table 3). Longer CPB times could reflect the shift in case
mix from isolated CABG to more combined CABG and val-
vular procedures observed (Tables 1 and 2). Although de-
creased internal thoracic artery use (associated with the
decline in isolated CABG procedures) is a possible mecha-
nism to explain decreased rates of DSWI, procedure type
was not an independent predictor of DSWI in the final mul-
tivariate analysis.
Prolonged operative time predisposes patients toward in-
fection directly through increased opportunities for inci-
sional contamination or tissue desiccation. Indirectly, long
procedures are associated with advanced disease, technically
difficult operations, and increased blood loss contributing to
tissue hypoxemia. The National Nosocomial Infection Sur-
veillance study identified wound class, American Society
of Anesthesiologists score, and prolonged operative times
as variables associated with increased rates of various surgi-
cal site infections.24 When the National Nosocomial Infec-
tion Surveillance index was applied to cardiac surgical
patients only, procedure duration was the sole factor that dis-
criminated between patients who acquired surgical site in-
fections and those who did not.25 In a study by Slais and
associates,26 an adjusted analysis demonstrated that increas-
ing CPB duration, by 30-minute increments, was indepen-
dently associated with infectious complications and, by
inference, DSWI. Because operative length is a potentially
modifiable risk factor, interventions to decrease it are war-
ranted; because of the increased case complexity of patients
currently undergoing open-chest procedures, however, sig-
nificant improvements in CPB time may be difficult to
achieve.
During the study period of 15 years, mortality of patients
with DSWI did not change significantly. Even in the modern
era, with muscle flaps and early diagnosis, DSWI remains
a lethal complication. Mortality benefits derived from im-
proved DSWI treatment may be offset by a cardiac surgical
population with increased rates of comorbidities, advancing
age, and often end-stage cardiovascular disease at the time of
surgery. This underscores the point that efforts should focus
on prevention of DSWI.
In conclusion, longitudinal analysis demonstrated a sig-
nificant reduction in the incidence of DSWIs. On the basis
of general health trends in the US population, patients
who require cardiac surgery can be expected to continue
to have higher rates of comorbidities that place them at
increased risk for DSWI. Reduced infection rates can be
achieved, however, by adjusting modifiable risk factors
at the time of admission. In our series, diabetes was elim-
inated as a risk factor for DSWI, probably as a result of
the introduction at our institution of both intraoperative
and postoperative intravenous administration of insulin.
Efforts should focus on modifiable risk factors, because
DSWI remains a major source of mortality in this large
series.ery c March 2010
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